DOCSLIB.ORG

Cannabis Industry and Edibles

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cannabis Industry and Edibles CANNABIS INDUSTRY AND EDIBLES LABOUR MARKET REPORT ABOUT US Food Processing Skills Canada (FPSC) is the food and beverage manufacturing industry’s workforce development organization. As a non-profit, located in Ottawa with representatives across Canada, we support food and beverage manufacturing businesses from coast to coast in developing skilled and professional employees and workplace environments. Our work directly and positively impacts industry talent attraction, workforce retention and employment culture. We care about assisting the industry in finding, training and retaining the very best people for the job. Through our partnerships with industry, associations, educators and all levels of This project was funded by the Government of Canada’s Sectoral Initiatives Program. governments in Canada, FPSC has developed exceptional resources for The opinions and interpretations in this publication are those of the author and do not the sector including the Food Skills Library™, Canadian Food Processors necessarily reflect those of the Government of Canada. Institute™, FoodCert™ and Labour Market Information Reports. ISBN 978-1-989541-56-2 Copyright © 2020 Food Processing Skills Canada All rights reserved. The use of any part of this publication, whether it is reproduced, stored in a retrieval system or transmitted in any form or by any means (including electronic, mechanical, photographic, photocopying or recording), without the prior written permission of the Food Processing Skills Canada is an infringement of copyright law. Food Processing Skills Canada 201 – 3030 Conroy Road Ottawa, Ontario K1G 6C2 Tel. (613) 237-7988 Toll Free: 1-877-963-7472 Fax: 613-237-9939 [email protected] www.fpsc-ctac.com Table of Contents Industry Overview ......................................................................................................................................................................................................................................4 History ..........................................................................................................................................................................................................................................................5 The Current Value of the Industry ..................................................................................................................................................................................................5 Existing license holders ............................................................................................................................................................................................................................6 Obtaining a Licence to Commercially produce Cannabis: Go Big or Go Home .....................................................................................................6 Overview .....................................................................................................................................................................................................................................................7 Canopy Growth Corp. ......................................................................................................................................................................................................................7 Aurora Cannabis ..................................................................................................................................................................................................................................7 Aphria .......................................................................................................................................................................................................................................................7 Canntrust Holdings ............................................................................................................................................................................................................................7 Tilray ..........................................................................................................................................................................................................................................................8 Cronos Group Inc. ...............................................................................................................................................................................................................................8 In the Queue ..........................................................................................................................................................................................................................................8 Key Positions in an LP ...............................................................................................................................................................................................................................9 License Holder ........................................................................................................................................................................................................................................10 Responsible Person..............................................................................................................................................................................................................................10 Head of Security ....................................................................................................................................................................................................................................10 Master Grower ........................................................................................................................................................................................................................................10 Quality Assurance Person ................................................................................................................................................................................................................10 Head of Laboratory .............................................................................................................................................................................................................................10 Corporate Services ...............................................................................................................................................................................................................................10 Retail – Provincial Breakdown ..............................................................................................................................................................................................................12 Retail and Distribution Overview ...................................................................................................................................................................................................12 Working with Indigenous Communities .....................................................................................................................................................................................13 Estimate of Direct and Indirect Jobs ............................................................................................................................................................................................... 14 Cannabis Export Market ........................................................................................................................................................................................................................ 15 International Experience ........................................................................................................................................................................................................................ 16 Edibles............................................................................................................................................................................................................................................................ 22 Where we see the Industry Going ................................................................................................................................................................................................... 26 Appendices ................................................................................................................................................................................................................................................. 32 Cannabis Industry Labour Market Report | FPSC 3 4 Cannabis Industry Labour Market Report | FPSC | Report Market Labour Industry Cannabis Industry Overview n October 7, 2018, Canada became the second country in the world, and the first G7 nation to fully legalize and regulate recreational cannabis. In Canada, the production O and sale of cannabis is regulated in essentially the same way alcohol is, with dual federal and provincial/territorial responsibilities. The government’s key motivation to legalize and regulate recreational cannabis was to make it more difficult for children
Load more

Recommended publications
  • Pioneering the Future of Global Cannabis June 2020
    Pioneering the Future of Global Cannabis June 2020 ©2020 TILRAY Disclaimer Investors and prospective investors should rely only on the information contained in the continuous expected; that adverse changes or developments affecting the Company’s main or planned facilities may Although management has attempted to identify important risk factors that could cause actual results to disclosure filings (the “Filings”) of Tilray Inc. (the “Company”). This presentation is qualified in its entirety have an adverse effect on the Company; that the medical cannabis industry and market may not continue differ materially from those contained in the forward-looking information in this presentation, there may by reference to, and must be read in conjunction with, the information contained in the Filings. An investor to exist or develop as anticipated or the Company may not be able to succeed in this market; that the be other risk factors not presently known to the Company or that the Company presently believes are not or prospective investor is not entitled to rely on parts of the information contained in this presentation to Company has a limited operating history and a history of net losses and that it may not achieve or maintain material that could also cause actual results or future events to differ materially from those expressed in the exclusion of others, and the Company is not authorized to provide different or additional information. profitability in the future; risks related to the Company’s current or proposed international operations; risks such forward-looking information in this presentation. There can be no assurance that such information Unless otherwise specified, all monetary amounts in this presentation are in United States dollars.
    [Show full text]
  • In Focus Cannabis Legalization 4
    IN FOCUS CANNABIS LEGALIZATION 4 2020 Developments in jurisdictions with measures regulating the non-medical use of cannabis of cannabis products for medical purposes had DEVELOPMENTS IN already been allowed in Canada as early as 1999. JURISDICTIONS WITH The objectives of the current cannabis legislation in MEASURES REGULATING Canada are to keep cannabis away from young people (under 18 years of age), to prevent criminals THE NON-MEDICAL USE from profiting from the distribution and sale of can- OF CANNABIS nabis and to safeguard public health and safety by allowing adults (aged 18 and older) legal access to As at December 2019, legal provisions had been cannabis.322 Under the constitutional division of approved in Canada, Uruguay and in 11 jurisdic- powers in Canada, the federal Government and pro- tions in the United States, including the District of vincial governments have different responsibilities.323 Columbia and the Northern Mariana Islands, to As the provinces historically developed their own allow the production and sale of cannabis products systems to regulate the sale of alcohol, a similar for non-medical use. The common feature of the approach has been applied to regulate the non-med- legislation in Canada and in the jurisdictions in the ical use of cannabis products. United States is that most of them allow for-profit To monitor the outcome of the new cannabis reg- industry to produce and sell cannabis products for ulations, the Government of Canada has invested non-medical use. There are some differences in the in a formal system that may eventually help to eval- level of regulation, its implementation and the con- uate their impact and support the further trol of the non-medical use of cannabis (see tables development of policies and programmes.
    [Show full text]
  • Actors and Incentives in Cannabis Policy Change: an Interdisciplinary Approach to Legalization Processes in the United States and in Uruguay
    1 UNIVERSIDADE DE SÃO PAULO INSTITUTO DE RELAÇÕES INTERNACIONAIS Fernanda Mena Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay São Paulo 2020 FERNANDA MELLO MENA 2 Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Original Version Ph.D. Thesis presented to the Graduate Program in International Relations at the International Relations Institute, Universidade de São Paulo, Brazil, to obtain the degree of Doctor in Science. Advisor: Prof. Dr. Leandro Piquet Carneiro São Paulo 2020 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. 3 Catalogação na Publicação* Instituto de Relações Internacionais da Universidade de São Paulo Mena, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay / Fernanda Mello Mena -- Orientador Leandro Piquet Carneiro. São Paulo: 2020. 195p. Tese (doutorado). Universidade de São Paulo. Instituto de Relações Internacionais. 1. Relações exteriores (História) – Brasil 2. Relações internacionais (História) - Brasil 3. Política externa – Brasil I. Mena, Fernanda II. Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay CDD 327.81 4 MENA, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Ph. D. Thesis presented to the International Relations Institute, at the University of São Paulo, Brazil, to obtain the degree of Doctor in Science.
    [Show full text]
  • The Highs and Lows of Startups in the Cannabis Industry: a Pestle Analysis of the Current Issues
    THE HIGHS AND LOWS OF STARTUPS IN THE CANNABIS INDUSTRY: A PESTLE ANALYSIS OF THE CURRENT ISSUES Jeffrey E. Anderson California State University, Los Angeles Mine Üçok Hughes California State University, Los Angeles Carlin Nguyen California State University, Los Angeles SUMMARY: With recreational cannabis now legal in ten US states, illegal cannabis growing operations are increasingly being replaced with regulated, taxed, and licensed businesses. Sales are predicted to increase roughly 35% from 2017, to more than $8 billion by the end of 2018, and to $22 billion by 2022. Projections like these have contributed to a startup boom in the cannabis industry unseen since the tech boom of the late 1990s. The aim of this paper is to highlight the unique issues faced by startups in the cannabis industry. We examine the elements that influence the cannabis startups by using the PESTLE framework which includes political, economic, social, technological, legal and ecological factors. We identify three types of cannabis startups and provide a brief analysis of differences between them as well as the challenges that they all face. Introduction With recreational use of cannabis currently legalized in ten US states, illegal cannabis growing operations are steadily being supplanted with regulated, taxed, and licensed businesses. Companies operating in these states are now able to legally produce and sell marijuana in their respective states. The 2018 Marijuana Business Factbook predicts sales to increase roughly 35% from 2017, to more than $8 billion by the end of the year (Marijuana Business Daily, 2018). By 2022, sales in the United States are projected to increase by 250%, to $22 billion.
    [Show full text]
  • WHO Cannabis Rescheduling and Its Relevance for the Caribbean
    Briefing paper August 2020 WHO cannabis rescheduling and its relevance for the Caribbean By Vicki J. Hanson, Pien Metaal and Dania Putri* Executive Summary • Actively engage with CND members, in particular Jamaica, the only English-speaking Following its first-ever critical review of Caribbean member of CND, emphasising cannabis, in January 2019 the World Health the urgent nature of recommendations 5.1 Organization (WHO) issued a collection of formal and 5.4. recommendations to reschedule cannabis and • Actively engage in relevant meetings and cannabis-related substances. 53 member states processes at the CND level, as well as of the Commission on Narcotic Drugs (CND), two emphasising the need for further follow- of which are Caribbean states, are set to vote on these recommendations in December 2020. ups to the critical review. • Actively engage and encourage support from Among the WHO’s recommendations, two other Caribbean governments and other key in particular appear to be the most urgent stakeholders such as CARICOM and OECS, and relevant for Caribbean countries: as well relevant civil society organisations, namely recommendation 5.1 (concerning experts, and affected communities. the acknowledgment of cannabis’ medicinal usefulness) and recommendation 5.4 (concerning Background: Cannabis and the the need to remove the term ‘extracts and UN drug scheduling system tinctures of cannabis’ from the 1961 Convention). Supporting these two recommendations Around the world, most national legislations presents an opportunity for Caribbean relating to the consumption, production, and governments and civil society to decolonise distribution of cannabis and cannabis-related drug control approaches in the region, as well substances are rooted in the current global drug as to strengthen the international legal basis for control system as institutionalised by the three 1 emerging medicinal cannabis programmes in main UN drug conventions.
    [Show full text]
  • Transitioning from Medical to Recreational WHAT CANNABIS RETAILERS NEED to KNOW CONTENTS
    Transitioning from Medical to Recreational WHAT CANNABIS RETAILERS NEED TO KNOW CONTENTS Transitioning from Medical to Recreational 5 Understanding Seed-to-Sale Tracking 10 How to be successful in the new recreational landscape 15 2 Recreational cannabis has taken the country by storm. In just a few years, it’s gone from being an illicit substance to a recreational one, sold and regulated in a similar way to alcohol. It’s now legal to sell flower, edibles, and other cannabis products for recreational use in Alaska, Colorado, Nevada, Oregon, and Washington. Soon, recreational markets will open in California, Massachusetts, Maine, and other states. Transitioning from a medical retailer to a recreational retailer presents an attractive business opportunity because of the significant increase in new customers – and revenue. Unfortunately, this isn’t a straightforward transition… CANNABIS LEGALIZATION STATUS • It can be challenging and expensive to obtain a recreational license. Medical cannabis broadly legalized • There are ever-changing regulations Cannabis legalized for recreational use you must comply with. No broad laws legalizing cannabis • And there are expenses you didn’t have to consider before. as of August 2017 At Green Bits, we’ve seen this transition happen in Alaska, Colorado, Nevada, and Oregon. We’ve been on the frontlines and helped hundreds of customers make the transition from medical to recreational. For this eBook, we talked to a host of store owners and managers who have been through the transition. We’ve learned how tough the transition can be, and which changes you’re likely to see. We’re here to prepare you as your state undergoes a market transition that will change how cannabis is bought and sold forever.
    [Show full text]
  • The Myth of Medical Marijuana
    DRUG FREE AUSTRALIA The ACT Medical Cannabis Conundrum Why legislate an inferior product? 1. The Greens Bill is premised on an ignorance of the currently legal status of medical cannabis 2. The Greens ‘medical’ Bill has not been requested by the medical establishment 3. The Greens Bill ignores 74% of addicted teens in Colorado sourcing cannabis from medical marijuana patients 4. The Greens Bill does not recognise that it is legislating trafficable quantities of cannabis 5. The Greens Bill, perhaps unwittingly, aligns with drug legalisation strategies worldwide 6. The Greens Bill ignores the heavily evidenced harms of crude cannabis to users and their community 7. The Greens Bill will proliferate recreational cannabis use, which most Australians condemn Central Issues & Compiled Evidence DRUG FREE AUSTRALIA Executive Summary - Seven Central Issues for ACT Legislators 1. The Greens Bill is premised on an ignorance of the currently legal status of medical cannabis ‘Medical Marijuana’, (which is a misnomer) has been legally used in Australia since the mid-1990s, when the THC capsule developed in the US called Marinol was imported into Australia under TGA Special Access for 100 patients. Marinol can be imported today under the same arrangement. Alternatively, the whole-leaf extract of cannabis, called Sativex, was approved by the Australian TGA in 2012 for MS spasticity. Both medications are pharmaceutically standardised in terms of dosage, strength and purity, which crude cannabis products are not. Both medications can be used for maladies where clinical trials have previously shown promise – nausea, AIDS wasting, chronic pain and MS spasticity. A third pharmaceutical medicine which is high in CBD, Epidiolex, is currently being tested in the US and could be tested here under similar arrangements – CBD is the element within cannabis believed to be responsible for the relief of severe seizures in epilepsy-like syndromes for some sufferers, including children.
    [Show full text]
  • Nurturing New Growth Canada Gets Ready for Cannabis 2.0 Table of Contents
    Nurturing new growth Canada gets ready for Cannabis 2.0 Table of contents Introduction 1 Cannabis 2.0: Canadian survey insights 4 Perspectives on Cannabis 2.0 22 The way forward: Thriving in a Cannabis 2.0 world 30 Remain bold 32 Nurturing new growth | Canada gets ready for Cannabis 2.0 | Introduction Introduction ll eyes remain on Canada as it prepares for the next stage of cannabis legalization—a step that will keep A the country firmly at the vanguard of a societal revolution and a new industry exploding with potential. “Cannabis 2.0” will see edibles containing cannabis and cannabis concentrates become legal on October 17, 2019. Their legalization will mean seven classes of cannabis products will be approved for sale in Canada, as dried cannabis, cannabis oil, fresh cannabis, cannabis plants, cannabis plant seeds, were legalized in 2018. The speed with which Canada’s cannabis industry has evolved over the past 18 months has been truly remarkable. In this, our third annual report on Canada’s cannabis industry, Deloitte has taken a broader approach in our research. As in previous years, we conducted comprehensive market research to understand Canadian consumer sentiment on cannabis edibles and other alternative products coming with Cannabis 2.0 legalization. The introduction of these new products is creating new opportunities in product mixes, reaching new cannabis consumers not fully comfortable with traditional consumption methods currently available. 1 Nurturing new growth | Canada gets ready for Cannabis 2.0 | Introduction As well, we explore trends and Our research suggests that the new However, we do need to acknowledge issues affecting the cannabis sector, alternative cannabis products becoming that Canada’s legal recreational drawing on extensive interviews and legal in late 2019 will be a significant cannabis industry is still in its infancy.
    [Show full text]
  • Alcohol, Cannabis and Impaired Driving
    ALCOHOL, CANNABIS AND IMPAIRED DRIVING July 11, 2018 R. Solomon, Distinguished University Professor, Faculty of Law, Western University; K. Mahdi, J.D. 2020, Faculty of Law, Western University; & A. Sohrevardi, J.D. 2020, Faculty of Law, Western University TABLE OF CONTENTS 2 INTRODUCTION .................................................................................................. 5 ALCOHOL ............................................................................................................... 7 PART I: ALCOHOL CONSUMPTION .......................................................................... 7 Section 1: Global ................................................................................................................. 7 Section 2: Alcohol Consumption in Canada .................................................................... 8 (a) Background Information ......................................................................................... 8 (b) Rates and Patterns of Alcohol Consumption ......................................................... 10 PART II: IMPAIRED DRIVING IN CANADA ............................................................... 15 Section 1: Rates of Driving After Alcohol Consumption ................................................ 15 Section 2: Impaired Driving Crashes ............................................................................... 17 (a) A Note on the Impaired Driving Crash Data ......................................................... 17 (b) Alcohol-Related Crash Deaths and
    [Show full text]
  • Economic Impact of Cannabis in San Diego County
    Economic Impact of Cannabis in San Diego County 2021 California State University San Marcos Cannabis Points of Contact: (CSUSM) Virginia Casey, Blue Water Government Office of Business Research and Analysis Affairs, Communications Director (OBRA) Dallin Young, Blue Water Government Affairs, 333 S. Twin Oaks Valley Road President San Marcos, CA 92096 www.csusm.edu/coba Research Team Leads: Johnny Martinez Cannabis Organization: Sofia Rodriguez Dallin Young President Research Team Members: Blue Water Government Affairs Amanda Boudreault Samantha Hoover Publishers: Riley McLaughlin Miguel de Jesus, CSUSM Liz Yocom Roger Herzler, CSUSM Judith Opdahl, CSUSM Layout: Amanda Boudreault Administrative Support Sofia Rodriguez Giselle Bazan For questions about this report, contact: Miguel de Jesus [email protected] (760) 750 - 4266 Executive Summary The cannabis industry has gone through many series of events that has brought it to the billion dollar industry it is today. Since its move from the illicit market, to the legalization of medicinal cannabis in 1996, and continued positive shifts of perceptions of cannabis, there has been exponential growth in the industry. The Office of Business Research and Analysis (OBRA) has analyzed the general impact of the cannabis industry in San Diego County. Throughout this research, OBRA sought to find how adult-use and medicinal cannabis sales increases in revenue and influences the community regarding finances, police enforcement, cannabis license types, public health, and social equity. The cannabis industry yields a considerable amount of revenue to municipalities from cannabis city taxes. Data from public records requests from the cities of San Diego, La Mesa, and Vista illustrate the amount of money by quarter that each city has brought in since their legalization of medicinal cannabis and or adult-use cannabis.
    [Show full text]
  • Cannabis in Canada: What the Upcoming Legalization of One of Canada’S Most Popular Drugs Means for Young People Braedon R
    LETTER Cannabis in Canada: What the upcoming legalization of one of Canada’s most popular drugs means for young people Braedon R. Paul1 Citation: UBCMJ. 2018: 9.2 (40-41) ith the Canadian legalization and regulation of cannabis slated term, some have shown residual effects lasting well beyond abstinence Wfor a debut no later than July 2018,1 many Canadians are eagerly of cannabis use,14 particularly if chronic and heavy use was initiated in awaiting the day when one of Canada’s most popular drugs2,3 can be earlier adolescence. Additionally, chronic use of smoked cannabis has legally purchased and consumed for recreational purposes. Bill C-45 been associated with symptoms of chronic bronchitis and large airway [the Cannabis Act], introduced to the House of Commons in early inflammation, while the links between smoking cannabis and lung 2017,4 is set to legalize and regulate the production, distribution, and cancer have been suggested by some but not conclusively determined.15 sale of recreational cannabis across Canada, fulfilling an election If the age limit is set too high, however, illicit sales from organized promise made by the Liberal Party of Canada [LPOC] in 2015.5 crime groups, which currently reap an estimated $7 billion annually Although many are in favour of the incoming legislation, an equally in Canada alone,16 will continue to supply the underage market—a vocal group has expressed concern over its pitfalls, particularly those substantial concern given that Canadian youth are understood to be regarding the potential impacts on Canadian youth. Given what is the highest young users of cannabis in the world3 and are more than currently understood about the effects of cannabis usage on adolescent double that of the general Canadian population.2 Inevitably, such high health, these concerns are not unwarranted.
    [Show full text]
  • Medical Cannabis Latin America & Caribbean
    MEDICAL CANNABIS LATIN AMERICA & CARIBBEAN SPECIAL REPORT 17 56 59 72 CULTIVATING BUSINESS PHARMACEUTICAL & MEDICAL SERVICES & TECHNOLOGY EVENTS Progressive, inclusive medical CBD popularity is surging across The medical cannabis industry A robust events industry cannabis policies can have a the continent as regulatory is birthing a range of secondary has grown around the significant social impact regimes jump to legalize it services across the region medical cannabis sector Image: Nader Ahmed, IndicaOnline Contents 1 FROM THE EDITOR’S DESK Managing Director LATAM Han Le Regional Director LATAM Federica Fermo Country Managers Blanca Bañares, Giulia Di Loreto THE BUSINESS YEAR: Country Editors Alejandra Gómez Arreola, Juan Pablo Vásquez Pedraza, Juan Manuel Mejía Salazar, Enrique José García, MEDICAL CANNABIS Daniel Alarcón Project Assistant LATIN AMERICA Angie Serrato Chief Executive Officer Ayşe Hazır Valentin Editor-in-Chief & CARIBBEAN Peter Howson Senior Editor Terry Whitlam Writer/Editor SPECIAL REPORT Evan Pheiffer Associate Editor Liz Colavita Chief Sub-Editor Shireen Nisha Sub-Editors Kabir Ahmad, Alia Kıran Editorial Coordinator Belemir Ece Çolak Web Editor Aidan McMahon Web Assistant & Social Media Coordinator Ahsen Durukan Web Developer Volkan Görmüş Assistant Web Developer Zişan Yalçınkaya Analytics Assistant Sena Özcanlı Art Director Emily Zier-Ünlü Junior Art Director Emre Boduç Senior Motion Graphic Designer Serkan Yıldırım he Business Year’s Special Report on market, and as the ideal exporter to its neigh- Motion Graphic Designer Medical Cannabis in Latin America bor and largest cannabis (medical or other- Yiğit Yeşillik T Senior Graphic Designers and the Caribbean is the second entry wise) market, the US, but has yet to clear the fi- Bilge Saka, Şule Kocakavak in our medical cannabis series, building upon nal obstacles in the country’s legal process and Contributors our inaugural report on the Colombian market.
    [Show full text]